Palvella Therapeutics, Inc. (PVLA)
Nasdaq: PVLA · Pharmaceutical Preparations · Wayne, PA · filing with the SEC since 2013
Who owns Palvella Therapeutics, Inc.
As filed with the SECHolders of 5% or more
7
Kaupinen Wes holds 14.6% of Common Stock, $0.001 par value per share, as its SCHEDULE 13D filed Dec 20, 2024 says.
Directors and officers
12
report now, of 37 people on the record since 2015. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 7 named at left.
Holders of 5% or moreshare of the class, as filed
Kaupinen Wes
SCHEDULE 13D · filed Dec 20, 2024 · Common Stock, $0.001 par value per share
Suvretta Capital Management, LLC
SCHEDULE 13G/A · filed Nov 13, 2025 · Common stock, $0.001 par value per share · 8.6% in Dec 20, 2024
Prudential Financial, Inc.
SCHEDULE 13G · filed Aug 10, 2026 · Common
Jennison Associates LLC
SCHEDULE 13G · filed Aug 3, 2026 · Common Stock
Frazier Life Sciences Public Fund, L.P.
SCHEDULE 13G/A · filed Feb 13, 2026 · Common Stock, $0.001 par value per share · 4.9% in Aug 14, 2025
Blackrock, Inc.
SCHEDULE 13G · filed Jul 29, 2026 · Common Stock
First Light Asset Management, LLC
SCHEDULE 13G/A · filed Aug 14, 2026 · Common Stock, $0.01 par value · 7.49% in Feb 17, 2026
Bvf Partners L P/il
SCHEDULE 13G/A · filed Aug 14, 2026 · Common Stock, $0.001 par value per share · reported falling below 5%, from 7.1% in Feb 17, 2026
Samsara BioCapital, L.P.
SCHEDULE 13G/A · filed Aug 14, 2025 · Common Stock, $0.001 par value per share · reported falling below 5%, from 6.1% in Dec 20, 2024
Dellora Investments LP
SCHEDULE 13G/A · filed Dec 17, 2024 · Common Stock, $0.001 par value · reported falling below 5%, from 10.7% in Dec 6, 2024
What PVLA reports owning in othersstakes of 5% or more, and other ties
2 subsidiaries in 2 countries, from the list filed with the 10-K filed Mar 31, 2026.
Insider tradesForm 4
76sales
3purchases
75sales on a scheduled plan
4people selling
$15.9Msold, in dollars
$800,000bought, in dollars
Open-market trades on Form 4 from Nov 12, 2025 to Nov 12, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2026 runs to Nov 12, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window5 of 51 on the roster
| Person | Role as filed | Sales | Sold | On a plan | Buys | Bought |
|---|---|---|---|---|---|---|
| Jenkins George M | director | 26 | $7.7M | 26 | 2 | $500,000 |
| Goin Kathleen | Chief Operating Officer | 36 | $6.0M | 36 | 0 | $0 |
| Martini Jeffrey S | Chief Scientific Officer | 13 | $2.1M | 13 | 0 | $0 |
| Heron Elaine J | director | 0 | $0 | 0 | 1 | $300,000 |
| Kiritsy Christopher P | director | 1 | $0 | 0 | 0 | $0 |